Among the patients with 2C4 risk factors, DM developed in 448 of 3,128 patients in the high-dose group and in 368 of 3,103 patients in the lower-dose groups - Expression of TNF inhibitor in Senescence and Aging

Among the patients with 2C4 risk factors, DM developed in 448 of 3,128 patients in the high-dose group and in 368 of 3,103 patients in the lower-dose groups

Among the patients with 2C4 risk factors, DM developed in 448 of 3,128 patients in the high-dose group and in 368 of 3,103 patients in … Continue reading Among the patients with 2C4 risk factors, DM developed in 448 of 3,128 patients in the high-dose group and in 368 of 3,103 patients in the lower-dose groups